USA: A recent study, published in JAMA Network Open as a research letter, highlights a significant link between anti-obesity ...

Researchers at Henry Ford Health, collaborating with WeightWatchers International, report that more than 40% of individuals ...

Nearly half of individuals consuming alcohol at baseline reduced their alcohol consumption following the initiation of AOMs.

A collection of common and new medications is showing good results against the constellation of symptoms that individualize ...

If made official, the proposed rule would give Part D and Medicaid beneficiaries expanded coverage to antiobesity drugs ...

A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be ...

University of Wisconsin–Madison biochemists have developed a new, efficient method that may give first responders, ...

Nearly half of participants in a weight-loss program who consumed alcohol at baseline began drinking less after adding an ...

University of Wisconsin–Madison biochemists have developed a new, efficient method that may give first responders, ...

This cohort study among individuals participating in a weight loss program found that nearly half of those consuming alcohol at baseline decreased their alcohol use after anti-obesity medication ...

“We really do need more tools in the toolbox.” Currently, the anti-addiction drug naltrexone is the most effective medicine approved for AUD, lowering the risk of hospitalization by 14 ...

The researchers also noted that the two GLP-1 drugs appeared to outperform standard anti-alcoholism medications, such as naltrexone, disulfiram and acamprostate, in lowering hospitalizations among ...